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Abstract
Background: Both depressive disorder and subclinical depressive symptoms during adolescence are a major public
health concern. Therefore, it is important that depression is detected at an early stage and is treated preventively.
Prevention based on the principles of Cognitive Behavioural Therapy (CBT) has proven to be the most effective, however
research has mainly focused on the effectiveness of “prevention packages” consisting of multiple CBT-components, rather
than on the distinct CBT-components. This study will evaluate the relative effectiveness of four core components of CBT
(cognitive restructuring (CR), behavioural activation (BA), problem solving (PS) and relaxation (RE)). In addition the relative
(cost-)effectiveness of four different sequences of these components will be evaluated: (1) CR – BA – RE – PS, (2) BA – CR
– RE – PS, (3) PS – GA – CR – RE and (4) RE – PS – BA – CR.
Methods: We will perform a non-blinded multisite cluster randomized prevention microtrial with four parallel conditions
consisting of the four sequences. The four sequences of components will be offered in groups of high school students
with elevated depressive symptoms. For each CBT-component a module of three sessions is developed. Assessments will
be conducted at baseline, after each CBT-component, prior to each session, at post-intervention and at 6-month follow-
up. Potential moderators and mediators will be evaluated exploratively to shed light on for whom the (sequences of)
CBT-components are most effective and how effects are mediated.
Discussion: The potential value of the study is insight in the relative effectiveness of the four most commonly used
CBT-components and four different sequences, and possible moderators and mediators in the prevention of depression
among adolescents. This knowledge can be used to optimize and personalize CBT-programs.
Trial registration: The study is registered in the Dutch Trial Register (Trial NL5584 / NTR6176) on October 13, 2016.
Keywords: Prevention, Depression, Adolescents, Cognitive behavioural therapy, Comparative effectiveness research, Cost
effectiveness
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Background
Depressive disorder during adolescence is a major public
health concern, as it is one of the most prevalent mental
disorders among adolescents (e.g., [1, 2]). The annual
prevalence of major depressive disorder is approximately
7.4% [1]. Lifetime prevalence of depression in adoles-
cents is estimated at 10.6% [1]. These percentages do
not even include adolescents with subclinical depressive
symptoms. Adolescent depression is associated with a
range of adverse consequences such as social isolation
[3], poor academic functioning [4], substance abuse [5],
suicidal behaviours [6], comorbid psychiatric diagnoses
[7, 8] and high societal costs [9]. Not only depressive
disorders but also subclinical levels of depressive symp-
toms put adolescents at risk for poor social and aca-
demic functioning [10, 11]. Furthermore, it puts
adolescents at risk for subsequent depressive disorders
later in life [12]. Therefore, it is important that depres-
sion is detected at an early stage and is treated prevent-
ively. Programs based on the principles of Cognitive
Behavioural Therapy (CBT) have proven to be the most
effective and most applied in preventing depression
among adolescents (e.g., [13]). Thus far, research has
mainly focused on effectiveness of prevention programs
as “packages” consisting of multiple CBT-components,
rather than on the distinct CBT-components. Little is
known about which specific components of CBT con-
tribute to the effectiveness of CBT-programs and in
what order these components should be offered (i.e.,
what their optimal sequencing is). Most common CBT-
components in current prevention programs for depres-
sion in adolescents are cognitive restructuring, behav-
ioural activation, problem solving and relaxation (e.g.,
[14–16]). However, few studies have examined the
effectiveness of these specific CBT-components and its
sequencing [17]. The planned study is aimed at dismant-
ling the relative effectiveness of core components of
CBT and its sequencing in the prevention of depression
among adolescents.
Cognitive restructuring is often seen as the fundamental
component of CBT. Cognitions play an important role in
the theoretical explanation of mood disorders (e.g., [18]).
Beck et al. [18] suggested that the way people think and
process information in response to stressors, is a primary
determinant of mood. In depressed individuals, negative
thoughts elicit a depressive mood, while positive thoughts
elicit happier moods. Negative thoughts are generated by
dysfunctional, negative and often unrealistic beliefs about
the self, the world and the future (the cognitive triad). The
aim of cognitive restructuring is to challenge these nega-
tive beliefs and to generate more realistic thoughts which
will help to improve mood [18, 19]. There is debate about
the necessity of focusing on cognitions in treating depres-
sion in adolescents as their cognitive ability to reflect on
their own core beliefs has not yet fully developed (e.g., [20,
21]). This might limit the application of cognitive restruc-
turing in this age group. Yet, there is some evidence for
the effectiveness of cognitive restructuring in preventing
(and treating) depression among adolescents. A recent
meta-analysis showed that preventative and curative CBT
including challenging thoughts (which is part of cognitive
restructuring) is associated with better outcomes than
CBT without this component, but only on the long term
[22]. Another meta-analysis showed similar effects of
interventions (preventive and curative) emphasizing cog-
nitive change (e.g. CBT and cognitive restructuring treat-
ments) and interventions without cognitive emphasis (e.g.
relaxation training) [23].
The CBT-component behavioural activation is theoret-
ically based on behavioural models of depression (e.g.,
[24, 25]), wherein it is suggested that depression is
caused or maintained by a lack of experiencing positive
reinforcement from the environment. This may occur
because people with depression lack the social skills re-
quired to elicit rewarding interactions with others and
often show avoidant behaviours [25]. Behavioural activa-
tion is aimed at increasing engagement in activities that
evoke positive reinforcement [26]. Behavioural activation
has proven to be an effective component in preventing
(and treating) adolescents’ depression (e.g., [22, 27–31]).
For example, the meta-analysis of Oud et al. [22] dem-
onstrated that preventive and curative CBT including
behavioural activation (in addition to challenging
thoughts, see previous paragraph) resulted in better out-
comes on the long term than CBT without behavioural
activation. Besides, a Randomized Controlled Trial
(RCT) showed that behavioural activation (as a standa-
lone program in only five sessions) was effective in redu-
cing depressive symptoms compared to no treatment in
a sample of late adolescents (aged 18–19) [30].
Problem solving refers to the cognitive-behavioural
process whereby people attempt to identify or discover
adaptive solutions to cope with specific problems arising
in daily living [32]. According to D’Zurilla and Goldfried
[33] problem solving comprise five different processes,
i.e. problem orientation, operationalizing problems/
goals, generating solutions, decision making, and imple-
menting and evaluating solutions. Longitudinal studies
have shown that deficiencies in any of these processes
play a role in the etiology of depression [34, 35]. Prob-
lem solving is directed at changing someone’s overall
problem-solving orientation, including the accompany-
ing problem-solving techniques [15, 33]. In the context
of prevention, problem solving has not (yet) been proven
effective. A RCT showed that five weekly sessions of
Problem Solving Therapy (provided as guided online
self-help) were not more effective in reducing symptoms
than a wait list control [36]. However, this result may be
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due to limitations of the study (e.g., limited power) [36].
It could be expected that problem solving is important
in the context of preventing depression among adoles-
cents as adolescence is a challenging and stressful period
wherein people are faced with a lot of developmental
challenges (e.g., making school/career decisions, devel-
oping new friendships, exploring self-identity, achieving
autonomy). The component of problem solving focuses
on improving problem solving skills to deal effectively
with these challenges [37]. In the context of treatment,
problem solving has proven to be effective on adoles-
cents’ depression. Kennard et al. [14] showed that CBT
including problem solving was associated with better
treatment outcomes than CBT without problem solving.
Chronically depressed adolescents who received CBT in-
cluding problem solving were 2.3 times more likely to
have a positive response than those who received CBT
without problem solving [14].
The CBT-component relaxation is based on the
diathesis-stress model for depression [38]. The model
states that stress may activate a diathesis or vulnerability,
transforming a predisposition for depression into an ac-
tual depression [38]. Relaxation is aimed at developing
strategies to cope with stress and to reduce its negative
effect on a someone’s vulnerability, for example through
relaxation exercises [38]. The effect of relaxation tech-
niques on depressive symptoms has rarely been exam-
ined in adolescents in both prevention and treatment
settings. One study showed equivalent effects of relax-
ation training and CBT (both 10 sessions) in treating de-
pression among adolescents [39].
Besides the specific components, current CBT-
protocols do not have a fixed sequence of components.
Even within one session often multiple components are
offered (see for example Coping with Depression course
for Adolescents (CWD-A), [40]). Nevertheless, patterns
can be distinguished. A quick review of four Dutch
CBT-protocols (The D(o) epression course (derived from
CWD-A), [41]; Pak aan (derived from Taking Action),
[42]; Op Volle Kracht (derived from the Penn Resiliency
Program), [43]; and Head up, [44]) showed that cognitive
restructuring is offered throughout all phases of treat-
ment, while behavioural activation is addressed in the
early and middle phase of treatment. The component of
problem solving is offered in the middle and final phase,
while relaxation techniques are taught in the middle
phase. Dobson [19] describes that a typical course of
CBT is composed of behavioural activation and problem
solving in the early phase of treatment and cognitive re-
structuring in the middle and final phase. Others suggest
that CBT should not consist of a fixed sequence of com-
ponents, but that the order of components should be
based on individual client characteristics and needs [45].
An example of such a personalized modular approach is
MATCH-ADTC (Modular Approach to Therapy for
Children with Anxiety, Depression, Trauma, or Conduct
Problems) by Chorpita and Weisz [46], which allows
great flexibility in the sequence of modules (and thus
components) based on a flowchart. To the best of our
knowledge, no studies investigated whether or not the
sequence of CBT-components is relevant for the effect
of CBT on depressive symptoms.
In sum, we know that CBT is effective in the prevention
of depression among adolescents, but we do not know
which components contribute most to its effectiveness
and what the optimal sequencing of components is [47].
Therefore, the current study aims to explore (1) the rela-
tive effectiveness of the four most commonly used CBT-
components in the prevention of depression among ado-
lescents (namely cognitive restructuring (CR), behavioural
activation (BA), problem solving (PS) and relaxation (RE))
and (2) the relative (cost-)effectiveness of four sequences
of CBT-components. First, we will examine and compare
the effectiveness of the four most commonly used CBT-
components. We hypothesize that all components are ef-
fective on adolescents’ depressive symptoms, but that
some components are more effective than others. Because
of insufficient evidence, we have no specific assumptions
about which components are more effective. Second, we
will examine and compare the effectiveness of four se-
quences of the most commonly used CBT-components.
As it is impossible to test all 24 possible combinations be-
cause of limited time and budget, we will only investigate
the three most logical sequences (condition 1: CR – BA –
RE – PS; condition 2: BA – CR – RE – PS; condition 3: PS
– GA – CR – RE) and the least logical sequence (condi-
tion 4: RE – PS – BA – CR). These four sequences are
based on current CBT-protocols, theory and close
consultation with mental health professionals. We
hypothesize that all sequences are effective on adolescents’
depressive symptoms, but that some sequences are more
effective than others. We expect that the conditions 1, 2
and 3 are more effective than condition 4. Furthermore,
potential moderators (e.g. severity of depressive symp-
toms, comorbidity and demographics) and mediators (fo-
cusing on the four components namely negative cognitive
errors, behavioural activation, problem solving skills and
relaxation) will be included to explore for whom and how
a component or combination of components works. At
last, the role of non-specific treatment variables (client ex-
pectancy of treatment, therapeutic alliance, groups cohe-
sion, cooperation with treatment, treatment satisfaction
and treatment adherence) will be taken into account.
Methods
The study methods and results will be reported in ac-
cordance with the CONSORT 2010 statement for
reporting parallel group randomized trials [48] and the
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extension to cluster randomized trials [49]. The medical
ethics committee CMO Region Utrecht in The
Netherlands approved this study (NL59152.041.16). The
study is registered in the Dutch Trial Register (Trial
NL5584 / NTR6176).
Design
The study is designed as a non-blinded multisite cluster
randomized prevention microtrial with four parallel con-
ditions to evaluate the relative effectiveness of four CBT-
components and four different sequences of these com-
ponents in adolescents at risk of depression. In all condi-
tions an indicated prevention program will be offered
consisting of four modules based on the four most com-
monly used CBT-components (cognitive restructuring
(CR), behavioural activation (BA), problem solving (PS)
and relaxation (RE)). Each module will consist of three
sessions. The sequence of the four modules will differ
per condition. The four conditions are shown in Table 1.
Assessments will be conducted at baseline (t0), during
the intervention phase after the first module (after three
sessions; t1), during the intervention phase after the sec-
ond module (after six sessions; t2), during intervention
phase after the third module (after nine sessions; t3), at
post-intervention (after twelve sessions; t4) and at 6-
month follow-up (t5). Additionally, prior to each session,
short individual measurements will be administered in
order to trace interim effects.
Participants’ eligibility
Adolescents in all grades of secondary education (from
pre-vocational education up to pre-university education)
are eligible to participate in the study. Inclusion criteria
for the adolescents are (1) aged between 10 and 20 years
old, (2) sufficient knowledge of the Dutch language and
(3) an elevated level of depressive symptoms at screening,
defined as a percentile score of 76 or higher based on the
Children’s Depression Inventory-2 (CDI-2; [50]) norm
scores (according to gender and age). Exclusion criteria
are (1) the absence of adolescents’ or parental consent (for
subjects aged younger than 16), (2) currently receiving
treatment for mood- or anxiety related problems and (3)
suicidal ideation (expressed as a score of 2 (“I want to end
my life”) on CDI-2 item 8 followed by a total score of 12
or higher on the suicide items of the Questionnaire asses-
sing Suicide and Self Injury (in Dutch: Vragenlijst over
Zelfdoding en Zelfbeschadiging; VOZZ, [51])). Adoles-
cents who are identified with suicidal ideation (at any time
point within the study), will be contacted within 48 h and
referred to a general practitioner which in turn can refer
to mental health care.
In order to minimize the number of false positives, an
eligibility check will be conducted at baseline assessment
(t0). However, adolescents who do not report an elevated
level of depressive symptoms anymore (compared to
screening) will not automatically excluded from the
study, because of the episodic course of depression. In
consultation with the adolescent it will be determined
whether or not he/she will participate.
Recruitment, screening and randomization
Adolescents will be recruited via secondary schools in
The Netherlands. All adolescents and their parents (for
subjects aged younger than 16) receive written informa-
tion about the screening and the study. After receiving
passive consent, adolescents will be screened with the
CDI-2 [50, 52] for depressive symptoms in order to se-
lect high-risk adolescents. Students with an elevated
level of depressive symptoms will be approached by
email and by phone to participate in the study. Written
informed consent from adolescents and parents (for sub-
jects aged younger than 16) will be obtained by the first
author (MvdH) by post or email prior to the initiation of
the study. Screening will continue until the planned
sample size is achieved (n = 256, see subheading ‘sample
size’).
Eligible and consenting students from the same school
will be stratified by gender (boy or girl) and age (12–13
years, 14–15 years, 16 years or older), because a meta-
analytic review found that CBT depression prevention
programs showed higher effect sizes for samples with a
higher rate of female participants and samples with older
participants (> 13.5 years) [53]. Then treatment groups
of on average five students (from the same school) will
be formed, which are the unit of randomization. The
treatment groups will be randomized as a cluster by the
first author (MvdH), to one of the four conditions, by
computer generated block randomization (with a block
size of four). Once randomized such a group of students
continues as a group receiving the preventive program,
with one therapist per group. Blinding of participants is
not possible, like in most psychological interventions.
However, allocation to the four conditions will be con-
cealed until the introductory meeting, which takes place
Table 1 Sequence of CBT-modules per condition
Condition 1 Condition 2 Condition 3 Condition 4
Module 1
(session 1–3)
CR BA PS RE
Module 2
(session 4–6)
BA CR BA PS
Module 3
(session 7–9)
RE RE CR BA
Module 4
(session 10–12)
PS PS RE CR
Abbreviations. CR Cognitive restructuring, BA Behavioural activation, PS
Problem solving, RE Relaxation
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after the baseline assessment has been completed. The
overall study design is shown in Fig. 1.
Sample size
The trial is well powered with n = 64 in each of the four
conditions (n = 256 in total) to detect a clinically relevant
effect (mean standardized difference, d) of d ≥ 0.33 as
statistically significant (at α ≤ 0.05, 2-tailed) with a power
of (1-β) ≥ 0.80 when the primary outcome (depressive
symptoms) is evaluated in a baseline adjusted analysis of
variance (ANCOVA) while also taking into account the
nesting in the data owing to the cluster randomized
trial.
More specifically, the power calculation was con-
ducted using Stata’s 14.2 sample size procedure (sampsi)
assuming that the evaluation would be carried out in a
baseline adjusted ANCOVA with one baseline assess-
ment and one follow-up (t1). The correlation (r) between
t0 and t1 (r = .80) was estimated from preliminary data.
This indicated that 52 respondents per condition were
required. In a next step, we calculated the design effect
of 1.22 while taking into account the intraclass correl-
ation coefficient (icc), the mean cluster size (m), the
Screening 
Recruitment 
Randomization
Allocation to 
condition 1
Allocation to 
condition 2
Allocation to 
condition 3
Allocation to 
condition 4
t0 assessment 
Cognitive 
restructuring
Behavioural 
activation
Problem 
solving
Relaxation
t1 assessment 
Behavioural 
activation
Cognitive 
restructuring
Behavioural 
activation
Problem 
solving
t2 assessment 
Relaxation Relaxation Cognitive
restructuring
Behavioural
activation
t3 assessment 
Problem
solving
Problem
solving
Relaxation Cognitive
restructuring
t4 assessment 
t5 assessment 
Module 1 
(session 1-3)
Module 2 
(session 4-6)
Module 3 
(session 7-9)
Module 4 
(session 10-12)
Exclusion
- age between < 10 and > 20 years old
- insufficient knowledge of the Dutch language
- no elevated level of depressive symptoms on CDI-2
No participation 
- absence of adolescents’ and parental consent (for 
subjects aged younger than 16) 
- currently receiving treatment for mood- or anxiety 
related problems
- prominent suicidal ideation on VOZZ
Fig. 1 Schematic overview of the study design. Note: Each module includes three sessions
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coefficient of variation (cv) of the cluster sizes. The icc
was estimated at 0.05, m and cv where estimated from
preliminary data at 5 and 0.30, respectively. Hence, 64
(52*1.22) participants per condition are needed or a total
n of 256. We will not increase the sample size at base-
line to compensate for dropout, because all analyses
will carried out in agreement with the intention-to-
treat principle.
The program
The prevention program is designed for indicated pre-
vention and will be offered in groups of about five ado-
lescents. The program is developed by the researchers
themselves, in close collaboration with CBT-therapists
and experts in the field. For each of the four most com-
monly used CBT-components a module of three sessions
is developed; one module with three sessions of cogni-
tive restructuring (CR), one module with three sessions
of behavioural activation (BA), one module with three
sessions of problem solving (PS) and one module with
three sessions of relaxation (RE). The modules were de-
veloped based on cognitive and behavioural theories, a
taxonomy that describes the techniques that diverse
CBT-components should comprise [22], current Dutch
CBT-protocols (e.g., The D(o) epression course, [41]; Op
Volle Kracht, [43]) and the MATCH-ADTC [46]. In each
step of this developing process, a group of certified
CBT-therapists and experts in the field was consulted.
Also John Weisz was consulted during the process
(December 2016).
The program consists of twelve sessions (4 compo-
nents * 3 sessions) of 45–60 min each. Prior to the pro-
gram an introductory meeting will take place which lasts
30 min. The program takes place at the participating
schools directly after school, one to two times a week
(depending on holidays and schools’ preferences). It will
be provided by certified alumni pedagogics/psychology,
who are trained in two-and a half days and supervised
by psychologists. Treatment adherence of participants
will be monitored by the therapists and stimulated if
necessary.
Study outcome measures
For an elaborate overview of study outcome measures,
see Table 2.
Screening measures
To assess the eligibility to participate, adolescents will be
screened for depressive symptoms using a self-report
questionnaire, the CDI-2 [50] which includes 28 items.
All items offer three graded options from 0 to 2, of
which one is chosen (e.g., 0 = “I am sad once a while”, 1
= “I am sad many times”, 2 = “I am sad all the time”),
with higher scores indicating more depressive symptoms
according to the adolescent. Item 8 measures the pres-
ence of suicidal ideation (0 = “I don’t think about end-
ing my life”, 1= “I think about ending my life, but I
would never do”, 2 = “I want to end my life”= 2). In case
a participant scores 2 on this item, the suicide items of
the VOZZ [51] will be administered to assess suicidal
ideation more extensively. The VOZZ consists of 39
items of which 8 items measure past and present suicid-
ality, therefore only these items will be administered.
Items are rated on a 5-point scale, ranging from “never/
no day” to “very often/every day”, with higher scores in-
dicating more self-reported suicidal ideation.
Primary outcome measure
The degree of depressive symptoms in adolescents will
be measured with the CDI-2 [50], as described in the
previous section. Both the full-length version (28 items)
and the short version (12 items) will be used. The full-
length version has good internal consistency, test-retest
reliability and convergent validity [50]. For the short 12-
item version, Dutch psychometric properties have not
been studied yet. Based on the dataset of the Dutch
CDI-2 manual, we calculated the internal consistency of
the short 12-version in the general population of adoles-
cents, which was acceptable (α = .76, n = 2246) [50].
Secondary outcome measures
In addition to the CDI-2, three Numerical Rating Scales
will be used to measure the core symptoms of depression
(depressed/irritable mood and loss of interest or pleas-
ure in nearly all activities) in the last week, ranging from
0 to 10. The first scale focuses on depressed mood (0 =
“very depressed”, 10 = “very happy”), the second on irrit-
able mood (0 = “very irritated”, 10 = “very relaxed”) and
the third on loss of interest or pleasure (0 = “no pleasure
at all”, 10 = “a lot of pleasure”). The scales are developed
by the researchers themselves, based on the core symp-
toms of Major Depressive Disorder specified in the
Diagnostic and Statistical Manual of Mental Disorders,
Fourth Edition, Text Revision (DSM-IV-TR; [54]).
The degree of depressive symptoms of the adolescent
according to the parent will be measured with the
CDI-2 parent version that contains 17 items [50].
Items are rated on a 4-point scale ranging from “not
at all” to “almost always”, with higher scores indicat-
ing more depressive symptoms according to the par-
ent. The internal consistency and convergent validity
are qualified as good [8].
The presence of a depression diagnosis will be mea-
sured by a semi-structured diagnostic interview, the
Kiddie-Schedule for Affective Disorders and Schizophre-
nia, present and lifetime version (K-SADS; [55, 56]). The
view of the adolescent, the parent and the independent
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clinician will be taken into account. Only the section of
affective disorders will be assessed. In previous research,
the concurrent and convergent validity of the K-SADS
was supported [55, 57], the interrater agreement was
high (range: 93 to 100%) and test-retest reliability was
excellent (.77 to 1.00) [55]. The K-SADS will be assessed
by independent master students pedagogics/psychology
and research assistants who will be trained and super-
vised in the K-SADS and depressive symptomatology.
They will be blind to the allocation of the participants.
The top three problems of adolescents will be mea-
sured with the Top Problems (TP) measure [58]. It mea-
sures adolescents’ problems of greatest concern at
baseline assessment. Adolescents are asked to list prob-
lems, they are concerned about most. When the list is
complete, the interviewer will obtain severity ratings for
each problem (“How big of a problem is this for you?”)
on a scale ranging from 0 (not at all) to 10 (very, very
much). Than the interviewer will repeat all problems
that the adolescent has identified and asks which one “is
the biggest problem right now?”. The problem identified
will be assigned as rank 1; then the interviewer asks for
the next biggest problem (rank 2), and the next (rank 3).
This will result in a ranked list of the top three prob-
lems. In our study, the top three problems will be re-
quested once (at baseline), by independent master
students pedagogics/psychology and research assistants
who are blind to the allocation of the participants. At
subsequent assessments, only the severity of the top
three problems will be rated by the adolescent. Psycho-
metric properties of the TP measure are qualified as
good [58].
As described in the previous section, suicidal ideation
will be measured with item 8 of the CDI-2 and 8 items
of the VOZZ [51]. The VOZZ has good internal
consistency and test-retest reliability [51].
The Dutch version of the EQ-5D-Y [59] will be used
to establish health-related quality of life as expressed in
Table 2 Overview of study outcome measures
Type of variable Domain/Concept Instrument Items Source Assessment
A P T t0 t1-t3 t4 t5
Primary outcome Depressive symptoms CDI-2 (FV)
CDI-2 (SV)
28
12
x
x
x x x x
Secondary outcome Depressive symptoms NRS for core symptoms of depression a 3 x x x x x
CDI-2 parent version 17 x x x x
Depression diagnosis K-SADS affective disorders x x x x x
Top three problems TP measurea 3 x x x x x
Suicidal ideation (if score 2 on item 8 CDI-2) VOZZ suicide items 8 x x x x x
Health-related quality of life EQ-5D-Y 6 x x x x x
Cost-effectiveness Healthcare costs Cost diary 21 x x x x
Moderators Depression severity K-SADS x x x x x
Comorbidity BPM 19 x x x x x
Demographics adolescent/parent/therapist x x x x
Mediators Negative cognitive errors CNCEQ-R (FV) CNCEQ-R (SV) 16
5
x
x
x x x x
Behavioural activation BADS (FV)
BADS (SV)
25
9
x
x
x x x x
Problem solving skills SPSI-R 10 x x x x x
Relaxation PSS-10 10 x x x x x
NRS for relaxation 1 x x x x x
Treatment characteristics Current and previous treatment VEHI 6 x x x
Expectancy of treatment PETS 7 x x
Therapeutic alliance TASC-r 12 x x x x
Groups cohesion GCQ-s 12 x x x
Cooperation with treatment CWT 5 x x x
Satisfaction treatment SSS 3 x x
Abbreviations: A Adolescent, FV Full-length version, NRS Numerical Rating Scale, P Parents, SV Short version, T Therapist, t0 Baseline assessment, t1–3 Intermediate
assessments, t4 Post-assessment, t5 6-month follow-up assessment.
aThese questionnaires will also be administered prior to each session
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quality adjusted life years (QALYs), with parallel forms
for adolescent and parent report. The questionnaire
comprises five dimensions: Mobility, Self-care, Usual ac-
tivities, Pain/discomfort and Anxiety/depression. Each
dimension has three levels: no problems (1), some prob-
lems (2) and a lot of problems (3), with higher scores in-
dicating a lower quality of life of the adolescent. The
questionnaire also comprises a Visual Analogue Scale
(ranging from 0 to 100) that records the adolescents’
health, where 0 is labelled as “worst imaginable health
state” and 100 as “best imaginable health state”. The reli-
ability and validity of the questionnaire have been estab-
lished [60].
Healthcare costs will be measured by registration of
health care usage and costs of the last three months
in a cost diary reported by the parent, which has
been used in previous research on anxiety and de-
pression [9, 61, 62]. Health care usage and costs that
will be registered are direct health care costs (e.g.,
psychologist, general practitioner and medication),
direct non-health care costs (e.g., informal care), in-
direct costs (monetary value of production losses
caused by absence and reduced productivity and
school) and out-of-pocket costs (e.g., own contribu-
tion and transport costs). Costs will be calculated
from the mental health care system’s perspective and
from a societal perspective.
Moderators
The severity of the depression will be rated on the
basis of the number of depressive symptoms (five to
six symptoms: mildly depressed, six to eight symp-
toms: moderately depressed, eight to nine symptoms:
severely depressed), the nature of symptoms (when
suicidal ideation is present, the severity will be rated
as severe) and the interference with daily functioning
in different contexts such as at school, at home and
in social life (one life area: mildly depressed, two to
three life areas: moderately depressed, four life areas:
severely depressed) as suggested by the Dutch guide-
line for depression in youth [63]. The rating will be
done by independent master students pedagogics/
psychology and research assistants, who are blind to
the allocation of the participants, based on the results
of the K-SADS interview [55, 56].
Comorbidity will be assessed with the Brief Problem
Monitor [1], with parallel forms for adolescent and par-
ent report. The questionnaire contains 19 items and
comprises three scales: Internalizing, Externalizing and
Attention Problems. Items are rated on a 3-point scale
ranging from “not true” to “very true”, with higher
scores indicating more comorbid problems. Psychomet-
ric properties are qualified as good [64, 65].
Demographic information of the adolescent, parents
and therapist will be gathered by adding questions to the
self-report questionnaires about gender, age, ethnicity
and education level.
Mediators
Negative cognitive errors will be measured with the Chil-
dren’s Negative Cognitive Errors Questionnaire-Revised
(CNCEQ-R; [66]), to track changes in the assumed me-
diator of cognitive restructuring, namely negative cogni-
tive errors. The questionnaire comprises 16 items, which
are divided into five categories: Underestimation of the
ability to cope, Personalizing without mind reading,
Mind reading, Selective abstraction and Overgeneraliz-
ing. Items are rated on a 5-point scale ranging from “not
at all like I would think” to “almost exactly like I would
think”, with higher scores indicating more self-reported
negative cognitive errors. For the total score, high test-
retest reliability and good internal consistency have been
established [66]. Because of limited time at the inter-
mediate assessments (t1 - t3), we will only administer five
items of the questionnaire (item 1, 4, 5, 9 and 14). For
each subscale we selected the item with the highest load-
ing based on the factor analysis of Maric et al. [66].
Behavioural activation will be assessed with the Be-
havioral Activation for Depression Scale (BADS; [67]), to
measure changes in activation and avoidance. The self-
report questionnaire contains four scales: Activation,
Avoidance/rumination, Work/school impairment and
Social impairment. Both the full-length (25 items) and
the short version (9 items) will be used. The short ver-
sion only contains the scales Activation and Avoidance.
Items are rated on a 7-point scale ranging from “not at
all” to “completely”. For all subscales, higher scores
mean greater intensity on a particular dimension (e.g.,
the higher the score on the Activation subscale, the
more activation). Psychometric properties for both the
full-length and the short version are qualified as accept-
able to good [68, 69].
Problem solving skills will be assessed with the 10-item
version of the Social Problem Solving Inventory-Revised
(SPSI-R; [70]), to track changes in someone’s approach
toward problem solving in daily life. Items relate to five
subscales: Positive problem orientation, Negative prob-
lem orientation, Rational problem solving, Impulsivity/
carelessness style and Avoidance style. Items on this
self-report questionnaire are rated on a 5-point scale
ranging from “not at all true” to “extremely true of me”.
For all subscales, higher scores reflect greater intensity
on a particular dimension (e.g., the higher the score on
the Positive problem orientation subscale, the more
positive problem orientation someone reports). Psycho-
metric properties have demonstrated good reliability and
validity [71].
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Relaxation will be measured with the Perceived Stress
Scale (PSS-10; [72]), to measure changes in the degree
to which someone appraises situations as stressful. The
scale consists of 10 items, which are rated on a 5-point
scale ranging from “never” to “very often”, with higher
scores indicating more self-reported stress. Psychometric
properties are qualified as acceptable [73]. In addition to
the PSS-10, a Numerical Rating Scale from 0 to 10 will
be used to measure relaxation in the last week, devel-
oped by the researchers themselves (0 = “very stressed”,
10 = “very relaxed”).
Treatment characteristics
Current and previous treatments for psychological prob-
lems, including complementary and self-help treatments,
will be administered with the inventory of History of
Treatments (VEHI; [74]). This questionnaire consists of
6 items.
Treatment integrity will be established by rating two
randomly chosen sessions that are video or audiotaped.
Ratings will be done by two independent researchers
and interrater reliability will be established.
In the context of this study, other treatment character-
istics will not be further described.
Incentives
To motivate participation in the assessments, we offer
adolescents and parents incentives of respectively 35 and
10 euros in total, regardless of study condition. Adoles-
cents will receive 5 euros per assessment and 5 euros
bonus after completing all six assessments. Parents will
receive 10 euros after completing all three assessments.
Data analysis
All analyses will be conducted according to the
intention-to-treat principle (i.e., all participants, as ran-
domised). Clustering of data will be taken into account,
considering that small treatment groups of students
(from the same school) will be randomized as a cluster
to one of the four conditions. For all analyses multilevel
mixed modelling in Stata [75] and Mplus [76] will be
used. The four conditions will be included as fixed ef-
fects (i.e., by using dummy variables). For treatments
groups random effects will be included [77]. Finally, the
schools will be included by using fixed rather than ran-
dom effects, because the between-school variability can-
not be estimated well with the small number of available
schools (we have included 11 schools so far). Possible
baseline differences between the four conditions in de-
pressive symptoms and demographic variables will be
analysed. Variables that show differences between the
four conditions will be entered as covariates in all
models. When the data collection is complete, all
members of the research team (MvdH, DB, FS, RE) will
have access to the full dataset.
Main effect of each of the CBT-components
To examine and compare the effectiveness of each of
the distinct CBT-components (cognitive restructuring,
behavioural activation, problem solving and relaxation),
depressive symptoms at intermediate assessment 1 (t1)
will be used as dependent variable to measure the effect
directly after receiving the first module.
Main effect of different sequencing
To investigate and compare the effectiveness of the four
different sequences of CBT-components, depressive
symptoms at post-assessment (t4) and 6-month follow-
up (t5) will be used as dependent variables to measure
the effect directly after treatment and six months after
treatment. Marginal means will be computed under the
linear mixed model and these will be used to graph the
impact on depressive symptom levels when the CBT-
components are being offered sequentially over time.
Moderation
To explore effect moderation, baseline depression sever-
ity, comorbidity and the adolescents’ demographics will
be used.
Mediation
Mediation analyses will be performed to investigate
whether negative cognitive errors, behavioral activation,
problem solving skills and relaxation are mediators in
the association between the type of CBT-component
and depressive symptoms (at t1) and between the se-
quence of CBT-components and depressive symptoms
(at t4 and t5).
Cost-effectiveness of different sequencing
Cost-effectiveness analyses will be conduct in accord-
ance with the CHEERS statement [78]. Cost data will be
interpolated to a period of nine months under the as-
sumption that data obtained with the cost diaries are
representative for the periods in between. Binary logistic
regression will be used to assess differences between the
conditions in the percentage of adolescents below the
percentile score of 76 based on the CDI-2 [50] norm
scores (according to gender and age) and depression-
free adolescents based on the K-SADS interview [55, 56].
In order to get insight in the uncertainty surrounding
subtotal and total costs and due to highly skewed cost
distributions, bootstrap simulations will be conducted.
The bootstrap method estimates the sampling distribu-
tion of a statistic through a large number of simulations,
based on re-sampling with replacement [79]. The results
based on 1000 bootstrap replications of the costs of the
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four conditions will be used to calculate 95% confidence
intervals (95% CI) around the cost-differences, based on
the 2.5th and 97.5th percentiles. Bootstrap simulations
will also conducted in order to quantify the uncertainty
around the incremental cost-effectiveness ratio (ICER)
[80], yielding information about the joint distribution of
cost and effect differences. The bootstrapped cost-
effectiveness ratios will be subsequently plotted in a
cost-effectiveness plane, in which the vertical line re-
flects the difference in costs and the horizontal line re-
flects the difference in effectiveness. The choice of
treatment depends on the maximum amount of money
that society is prepared to pay for a gain in effectiveness,
which is called the ceiling ratio. Therefore, the boot-
strapped ICERs will be depicted in a cost-effectiveness
acceptability curve showing the probability that a condi-
tion is cost-effective using a range of ceiling ratios. Also
secondary (including QALYs based on the EQ-5D-Y)
and sensitivity analyses will be performed to test the ro-
bustness of the results.
Discussion
This study protocol presents the design of a multisite
cluster randomized prevention microtrial, which will
evaluate the relative effectiveness of four of the most
commonly used CBT-components in the prevention of
depression among adolescents and different sequences
of these components. In addition, the cost-effectiveness
of the different sequences will be examined. Further-
more, potential moderators and mediators will be in-
cluded to explore for whom and how a given component
or set of components is effective. Also the role of non-
specific treatment variables will be taken into account.
Strengths and limitations
To the best of our knowledge, this is the first experi-
mental study that dismantles the effectiveness of the
four most commonly used CBT-components in the pre-
vention of depression among adolescents (i.e., cognitive
restructuring, behavioural activation, problem solving
and relaxation) in order to identify the most effective
components of CBT and the optimal sequence of these
components. An additional strength of the study is that
we will not only focus on the effectiveness of the various
components and sequences, but that also potential mod-
erators and mediators will be explored. This will shed
light on for whom the different components and se-
quences are most effective and how effects are mediated.
Besides, the cost-effectiveness of the different sequences
of components will be investigated, which is important
because of diminishing budgets in mental health care.
Furthermore, not only self-report, but also a clinical
interview (K-SADS) will be conducted by independent
and blinded assessors which enables us to examine
the presence of a depressive diagnosis. In addition,
the TP measure will be used which can complement
standardized assessment as it comprises a client-
guided approach [58].
The study also has limitations. We will not include a
control group, limiting the extent to which a decrease in
depressive symptoms in the four intervention groups
can be uniquely ascribed to the prevention program.
The reason for this is that several meta-analyses and re-
views have already established the superior effect of CBT
in comparison to waitlist and placebo (e.g., [81–83]).
Another limitation is the design of a cluster randomized
trial, because of the great risk on baseline imbalance be-
tween study arms [84]. We will try to reduce this risk by
stratifying students by gender and age. The study’s
power is also a limitation. Although the study is well
powered on the main effects, the power might be too
low for conducting moderation analyses. Therefore,
these analyses will be done exploratory. At last, given
previous prevention trials, we expect a high number of
dropout in both the assessment and intervention phase,
which will have consequences for the effectiveness [85].
In order to motivate adolescents to participate in the as-
sessments, we will provide incentives for participation.
Besides, all treatment drop-outs will be asked to
complete the post- and 6-month follow-up assessments.
To prevent the effect of dropout on the effectiveness, all
analyses will be conducted according to the intention-
to-treat principle.
Implications for practice
The potential value of the study is that we gain insight
in the relative effectiveness of the four most commonly
used CBT-components and different sequences of com-
ponents, and possible moderators and mediators in the
prevention of depression among adolescents. This know-
ledge can be used to develop recommendations to
optimize and personalize CBT-programs in the preven-
tion of depression in adolescents. Knowing what works
for whom and how in preventing depression among
youth with CBT, could enable a matching process be-
tween the individual client and the most beneficial com-
ponents. For example, some components could be
omitted to prevent depression in some clients while
maintaining the effectiveness and increasing the cost-
effectiveness. In such a way, we can personalize indi-
cated prevention for depression in youth that meets the
individual needs and thereby enhance effectiveness.
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